Abstract
This article reviews our efforts in the development of indole melatonin (MLT) agonist and antagonist compounds. Evidence is presented which indicates that high-affinity melatonergic agonists were obtained by shifting the MLT amido side chain from the C-3 to the N-1 indole position. Conversely, by moving the side chain from the C-3 to the C-2 indole position it is possible to produce MLT antagonist compounds.
MeSH terms
-
Animals
-
Brain / metabolism
-
Drug Design
-
Humans
-
In Vitro Techniques
-
Indoles / chemistry
-
Indoles / pharmacology
-
Kinetics
-
Melatonin / agonists*
-
Melatonin / antagonists & inhibitors*
-
Melatonin / chemistry
-
Receptors, Cell Surface / metabolism
-
Receptors, Cytoplasmic and Nuclear / metabolism
-
Receptors, Melatonin
-
Structure-Activity Relationship
Substances
-
Indoles
-
Receptors, Cell Surface
-
Receptors, Cytoplasmic and Nuclear
-
Receptors, Melatonin
-
Melatonin